Hcplive
Published October 5, 2026
Q3 2026 Recap: Psychiatry News and Updates - HCPLive
Read the full story at Hcplive
Centanafadine's ADHD approval, the MDMA NDA resubmission, DT120 phase 3 wins, and the FDA psychedelic hearing headline Q3 2026 psychiatry news.
Surfaced by 2 Google Alerts
- Psychedelics
- MDMA